1. Home
  2. CYRX vs SENS Comparison

CYRX vs SENS Comparison

Compare CYRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYRX

CryoPort Inc.

HOLD

Current Price

$14.05

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$5.73

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYRX
SENS
Founded
1999
1996
Country
United States
United States
Employees
1100
130
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
419.3M
301.2M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
CYRX
SENS
Price
$14.05
$5.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$13.31
$18.38
AVG Volume (30 Days)
562.1K
1.1M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
156.22
N/A
EPS
N/A
N/A
Revenue
$176,177,000.00
$16,389,000.00
Revenue This Year
$11.06
$74.15
Revenue Next Year
$8.45
$58.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.85
52 Week Low
$5.31
$0.41
52 Week High
$13.79
$8.75

Technical Indicators

Market Signals
Indicator
CYRX
SENS
Relative Strength Index (RSI) 74.79 46.15
Support Level $7.98 $5.26
Resistance Level N/A $5.94
Average True Range (ATR) 0.75 0.44
MACD 0.08 0.03
Stochastic Oscillator 92.82 81.30

Price Performance

Historical Comparison
CYRX
SENS

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: